Study population
During 1943Ð90, breast cancer was diagnosed in 2860 women born in 1935 or later before they reached 40 years of age. These early-onset breast cancer patients were identified from the files of the Danish Cancer Registry, which also provided the patientsÕ names, dates of birth and unique personal identification numbers. The last, which incorporates sex and date of birth and permits accurate linkage of information between registers, was available for 2850 women alive on 1 April 1968, when the Central Population Register (CPR) was established in Denmark and for one woman born after that date. Linkage to the files of the CPR provided information on the date of death or date of emigration. For nine women who died before 1 April 1968, the date of death was obtained manually from the Death Certificate File at the National Board of Health. Nearly 40% of the women studied were under the age of 35 when their breast cancer was diagnosed (Table 1) .
Identifying relatives
Parents of these women were identified in one of two ways. When the personal identification number was available, computerized linkage with the files of the CPR readily identified the name, identification number and date of death or emigration (if applicable) of each parent. If the breast cancer patients or one or both of the parents had died before 1 April 1968, information about the parents had to be obtained manually from Ôparish registriesÕ, that is the population registers of the localities in which the families had lived at the date of birth of the cancer patient. Parents identified in this manner were then traced by computer in the CPR (parents of the nine breast cancer patients who died before 1 April 1968) or traced manually in the Death Certificate File (parents deceased before 1 April 1968) to verify personal data and dates of death. This parental search revealed that 20 pairs of the young breast cancer patients were sisters. Overall, 2670 different mothers (94%) and 2587 different fathers (91%) were found (Table 2) .
Sisters and brothers of the women with early-onset breast cancer were also located in the files of the CPR by using the personal identification number of the mother or from local parish registers. For the 20 pairs of sisters with early-onset breast cancer, the sister who was youngest at the time of diagnosis was regarded as the proband of the family. A total of 2156 sisters and 2354 brothers (of 2840 probands) were identified. The offspring of the young breast cancer patients were located through the CPR from the personal identification number of their mother. A total of 2544 daughters and 2662 sons (likewise of 2840 probands) were identified.
Identifying cancer in patients and relatives
Data on the women with early-onset breast cancer and their relatives were linked with the Danish Cancer Registry, using the study subjectsÕ personal identification numbers or, if they had died before 1 April 1968, their date of birth, date of death and name. The period of follow-up for the occurrence of cancer among women with early-onset breast cancer extended from the date of the initial breast cancer to the date of death or emigration or until 31 December 1993, whichever came first. The period of follow-up for the occurrence of cancer among parents extended from the date of birth of the proband with breast cancer, and that among siblings and offspring from the date of birth to the date of death or emigration to 31 December 1993. Cancers, including benign tumours of a Includes 20 pairs of sisters with early-onset breast cancer. , 1957) . The national incidence rates for these categories of tumour, calculated according to sex, age (in 5-year groups), and 5-year historical periods, were applied to the personÐyears of observation for each study cohort to obtain the number of cancers that would have been expected if they had had the same rates of incidence as the general population.
Statistical analysis
The statistical methods were chosen on the basis of the assumption that the observed number of cases of cancer in any specific category follows a Poisson distribution. Significance and confidence intervals for the standardized incidence ratio (SIR) Ð the ratio of the observed to the expected number of cancers Ð were calculated, with use of the Miettinen exact confidence limits if the observed number of cases was small; otherwise, an accurate asymptotic approximation was used (Rothman and Boice, 1979) . Account was also taken of the age of the proband at the time of the initial diagnosis of breast cancer and the age of the relatives at the time of cancer diagnosis. Separate analyses were performed for relatives of probands with contralateral breast cancer (n = 201) and probands with a second primary cancer of the ovary (n = 20).
RESULTS

Second malignant neoplasms
Breast cancer was diagnosed in almost 60 women per year before the age of 40 during the years 1943Ð90 in Denmark. A total of 2860 patients accrued 23 000 personÐyears of follow-up (average 8.0 years; range >0Ð39.5 years), during which time 268 new primary cancers developed, with 68.9 expected, yielding a SIR of 3.9 (95% CI 3.4Ð4.4) ( Table 3 ) and a cumulative risk after 25-years of followup of 31%. The excess 200 cancers consisted mainly of tumours of the contralateral breast (SIR 7.4; n 181) and ovarian cancer (SIR 6.0; n 20). A small but significant increase in risk was seen for cancers at all other sites combined (SIR 1.6). The risk for cancer of the endometrium was elevated (SIR 2.7) but not significantly. Cancer of the lung was significantly elevated (SIR 2.7), as was the risk of cancer of the liver though based on only two cases. Thyroid cancer was increased but not significantly, based on only two cases. Twenty-one women with synchronous bilateral cancer were not included in the risk estimates for second primary breast cancers.
Female relatives
The 2670 mothers of women with early-onset breast cancer represented nearly 110 000 personÐyears of follow-up (average 41 years; range >0Ð51 years). The 2156 sisters represented some 93 000 personÐyears (average 43 years; range >0Ð51 years). Over the entire follow-up period, 889 malignancies were diagnosed in mothers and 196 in sisters, yielding SIRs of 1.3 (95% CI 1.2Ð1.4) and 1.6 (1.4Ð1.8) respectively (Table 4 ). Significant excess risks were seen for cancers of the breast (mothers SIR 2.0; sisters 2.6), ovary (mothers 1.7; sisters 1.9), and other sites combined (mothers 1.1). The mothers also had significantly increased risks for cancers of the cervix (SIR 1.4) and colon (SIR 1.2), whereas the SIR for cancer of the brain (0.6) was below that expected. No other significant deviations were seen among mothers or sisters, although seven cases of leukaemia were observed among sisters with 3.0 expected. The cumulative risk for breast or ovarian cancer in the mothers was 3.8% vs 1.5% expected at the 20-year follow-up point and 12.1% v 6.2% expected at 40 years. The cumulative risk in sisters was 1.7% v 0.6% at 40 years.
A total of 2544 daughters of women with early-onset breast cancer were identified, representing approximately 56 000 personÐyears of follow-up. Their average age in 1993, however, was only 21.6 years. Nine cancers were observed compared with 10.7 expected, yielding a SIR of 0.8 (95% CI 0.4Ð1.6). Of these, two were breast cancer, diagnosed at the ages of 26 and 31, compared with 0.4 expected (SIR 5.0; 95% CI 0.4Ð18). Two cases of leukaemia (1.7 expected) and one case of brain cancer (2.3 expected) occurred in daughters, whereas no bone or connective tissue sarcomas were seen (data not shown).
The relative risks for cancers of the breast (Table 5 ) and ovary (Table 6 ) among first-degree female relatives were inversely related to the age at diagnosis of early-onset breast cancer in the proband. That is, the younger the proband, the higher the risks for breast and ovarian cancers in her mother and sisters. Further, there was a tendency for these tumours to occur earlier in life if the proband was diagnosed with breast cancer at an early age. The occurrence of bilateral breast cancer or breast plus ovarian cancer in a proband was a strong predictor of breast and ovarian cancers among female relatives (Table 7) . Of the 201 probands with bilateral breast cancer, 31 of their 191 mothers (16%) and 25 of their 186 sisters (13%) developed cancers of the breast or ovary. Of the 20 probands with breast cancer and subsequent ovarian cancer, 8 of their 19 mothers (42%) and 5 of their 23 sisters (22%) also developed one of these malignancies. Figure 1 shows the cumulative risk of breast or ovarian cancer by the age of the mothers and sisters up to age 75 years, compared with corresponding risk estimates for the general population. Approximately 15% (one in seven) of mothers and sisters of women with early-onset breast cancer were diagnosed with breast or ovarian cancer before age 75 vs 8% (1 in 12) in the general population. The familial risk increased from 14% when the probands were diagnosed at ages 35Ð39 to 18% when the probands were diagnosed under the age of 35. The cumulative incidence by age 75 reached 24% (one in four) among mothers and sisters of probands with bilateral breast cancer or with breast and subsequent ovarian cance r.
Male relatives
Among the 2587 fathers of women with early-onset breast cancer (personÐyears of follow-up 97 000; average 37 years; range, 0.3Ð51 years), 798 cancers were recorded, with 744.7 expected, yielding an SIR of 1.1 (Table 8) . Among the 2354 brothers (personÐyears of follow-up, 101 000; average 43 years; range Obs, number observed; Exp, number expected. Obs, number of cases observed. a P <0.05. >0Ð51 years), 107 cancers were seen, with 89.6 expected, yielding a SIR of 1.2. Most prominent were the risks for breast cancer among the fathers (SIR 2.5; 95% CI 0.5Ð7.4) and brothers (29; 7.7Ð74), although based on small numbers. Significantly increased risks were also seen for cancer of the buccal cavity and pharynx (SIR 1.4), non-melanoma skin cancer (1.2), and non-HodgkinÕs lymphoma (1.6) in fathers. A total of 2662 sons of women with early-onset breast cancer were found, representing approximately 58 000 personÐyears. Their average age in 1993 was only 21.8 years. Nine cancers were observed, with 13.4 expected, yielding an SIR of 0.7 (95% CI 0.3Ð1.3). Three cases of malignant melanoma were seen compared with 0.5 expected (SIR 6.4; 1.3Ð19). There were no cases of male breast cancer, leukaemia, sarcoma or brain cancer.
Childhood tumours
A total of 127 000 personÐyears of follow-up were accrued during childhood, i.e. ages 0Ð14 in the combined group of daughters and sons (73 500 personÐyears) and sisters and brothers (53 500 personÐyears). Overall, 26 cancers were observed, with 16.8 expected (SIR 1.6; 95% CI 1.0Ð2.3). Of these, nine were leukaemias vs 5.5 expected (1.6; 0.8Ð3.1), six were brain tumours vs 4.9 expected (1.2; 0.5Ð2.7), three were non-HodgkinÕs lymphomas vs 1.0 expected (2.9; 0.6Ð8.5), two were HodgkinÕs disease vs 0.5 expected (4.3; 0.5Ð16), and two were cancers of the buccal cavity and pharynx vs 0.2 expected (13; 1.5Ð48). The remaining four cases consisted of a mediastinal tumour, liver cancer (not specified as primary), cutaneous melanoma, and cancer of unspecified site. There were no sarcomas of bone or connective tissue.
DISCUSSION
Women who develop breast cancer before the age of 40 are at very high risk of developing a subsequent breast or ovarian cancer, with the overall relative risk reaching sevenfold in our study. This substantial excess risk is probably due to genetic predisposition, although radiotherapy given to young patients may contribute to the occurrence of contralateral breast cancer Storm et al, 1992) . For mothers and sisters of women with earlyonset breast cancer, the overall relative risk for breast and ovarian cancer was twofold, and the cumulative risk at 75 years of age was 15% in comparison with 8% expected in the general female population of Denmark. Consistent with other studies of families with breast and ovarian cancers (Claus et al, 1990; Slattery and Kerber, 1993; Teare et al, 1994; Peto et al, 1996) , the earlier the age at onset of breast cancer in the proband, the greater the familial risk of breast or ovarian cancer. The lifetime risk rose further, to about 24%, when the proband had bilateral breast cancer or subsequent ovarian cancer. These results cannot readily be explained by recall or selection bias, because all family members during a 50-year period in the entire country of Denmark were identified from national population and church registers, and cancer occurrence was determined from national cancer registry files. Germline mutations of the BRCA1 susceptibility gene are estimated to account for about 3% of all breast cancers and 4Ð5% of all ovarian cancers (Ford et al, 1995; Whittemore et al, 1997) . If all of the excess breast and ovarian cancers in the mothers of women who developed breast cancer under the age of 40 in our study were associated with inherited mutations, 6.3% of the mothers (169 of 2670) would have transmitted a susceptibility gene to their daughters. Taking into account that some women with family histories may have mutations in genes other than BRCA1, this estimate is consistent with the approximately 6Ð13% prevalence of BRCA1 mutations found in sporadic cases of breast cancer in women under the age of 35 (FitzGerald et al, 1996; Langston et al, 1996; Struewing et al, 1996; Malone et al, 1998) , with about half of the mutations inherited from mothers and half from fathers.
Population studies in Iceland and the United Kingdom have also reported familial aggregation of incident or fatal cases of breast and ovarian cancers in relatives of young breast cancer patients, with relative risks similar to those we observed (Anderson et al, 1992; Tulinius et al, 1992b; Teare et al, 1994; Peto et al, 1996) . Some population and family studies of breast cancer have also suggested excess risks for cancers of the colon (Goldgar et al, 1994) , endometrium (Anderson et al, 1992; Tulinius et al, 1992a; Peto et al, 1996) , and prostate (Tulinius et al, 1992b; Anderson and Badzich, 1993; Sellers et al, 1994; Tulinius et al, 1994; Struewing et al, 1997) , but our findings are consistent with studies (Schildkraut et al, 1989; Negri et al, 1997) showing no elevated risk for these tumours except possibly colon cancer in mothers. The excess risk for cervical cancer we observed in mothers did not extend to the sisters or daughters and probably represents a chance occurrence. A significant increase in the risk for lung cancer among the probands may be related to radiotherapy (Inskip et al, 1994) rather than to inherited factors, although a slight nonsignificant increase in the risk for lung cancer was noted in mothers and sisters suggesting familial patterns of tobacco use.
Despite its rarity, the risk of male breast cancer was significantly elevated in accord with family studies indicating a genetic susceptibility to male and female breast cancer, due especially to germline mutations of BRCA2 (Stratton and Wooster, 1996) . The gene for CowdenÕs disease has recently been identified as PTEN (Li et al, 1997) , and may contribute to familial occurrences of breast cancer as well as thyroid cancer.
In LiÐFraumeni syndrome, mutations in the p53 gene are responsible for the familial constellation of early-onset breast cancers and other tumours of young people, notably sarcomas of soft tissue and bone, acute leukaemia, brain tumours and adrenocortical neoplasms (Li et al, 1988; Garber et al, 1991; Varley et al, 1997) . In a previous population-based incidence study of cancer Obs, number observed; Exp, number expected.
risks among the parents of all children with cancer in Denmark, we were able to detect a familial association between early-onset breast cancer and childhood sarcoma (Olsen et al, 1995) . The current approach covered nearly 50 years of breast cancer incidence in Denmark, but still had insufficient statistical power to thoroughly assess the constellation of tumours associated with rare genetic conditions such as LiÐFraumeni syndrome. Thus, our population-based survey of cancer incidence among close relatives of women with early-onset breast cancer in Denmark suggests that susceptibility genes to breast cancer contribute to only a small percentage of non-mammary malignancies other than those of the ovary.
